Du Ying, Chairperson and CEO of Zai Lab Limited (ZLAB), has been a consistent seller of company stock over the past year, with no open-market purchases recorded in her SEC Form 4 filings. Across 61 total transactions, she has disposed of approximately $15.9 million in shares while acquiring no stock through purchases or grants. The selling pattern is concentrated in the spring and summer of 2026, with the most intense activity occurring in mid-May, when she executed five separate open-market sales totaling roughly $4.0 million between May 13 and May 18. Additional sales in late June brought in about $559,000, and smaller dispositions in early April added roughly $168,000.
The recent filings reveal a clear directional bias toward monetization rather than accumulation. Every open-market sale (code S) was paired with an option exercise (code M) at a nominal value, indicating that Du Ying is converting vested options into shares and immediately selling them. For instance, on May 13 she exercised options valued at $87,000 and sold shares worth $998,469; similar pairings occurred on May 14, May 15, and May 18. The largest single transaction was a $2.2 million tax-withholding event (code F) on May 19, which is an automatic deduction of shares to cover option-exercise taxes rather than a discretionary trade. Three gifts (code G) in late May involved no cash consideration.
Notably, Du Ying has not made a single open-market purchase (code P) during the entire period covered by the filings, and her most recent trades—a July 2 award (code A) and associated tax withholding—continue the pattern of compensation-driven activity rather than voluntary buying. The absence of any acquisition activity, combined with the steady stream of option-exercise-and-sell transactions, paints a picture of an executive systematically reducing her equity exposure in Zai Lab, though the filings themselves offer no insight into her reasoning.
AI-assisted summary